For better monitoring of tumor molecular changes, liquid biopsy is emerging as a more convenient and potentially lower-cost alternative to tissue biopsy. Liquid biopsy detects genetic aberrations in circulating tumor cells and deoxyribonucleic acid from apoptotic and necrotic tumor cells.
Hongjun Kang (email@example.com) is a senior physician and associated professor at the Chinese PLA General Hospital. He received his Ph.D. degree in surgery from the Chinese PLA medical school, Beijing, China, and a bachelor’s degree in clinical medicine from Chengde Medical School, China. He is interested in biomarkers diagnostics for sepsis and infectious disease.